MedPath

Validation of B.O.L.T Spirometer Device to test functioning of lungs with comparision to another Spirometer available in the market.

Not Applicable
Completed
Conditions
Health Condition 1: null- 1. COPD2. Asthma3. Chronic bronchitis4. Emphysema5. Pulmonary fibrosis 6. Patient on a bronchodialator therapy
Registration Number
CTRI/2018/09/015691
Lead Sponsor
American Megatrends India Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
91
Inclusion Criteria

1. Subject is willing to give written informed consent for participation in the study.

2. Male or Female, aged 18 years or above.

3. Subjects suffering from any respiratory disorder (COPD, Asthma, Chronic bronchitis, Emphysema and Pulmonary fibrosis)

4. Patient on a bronchodialator therapy

Exclusion Criteria

1. Mentally retarded subjects

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity and specificity of the device with respect to the qualitative evaluation of the tracings with subsequent equivalent of <br/ ><br>1. Volume of air inhaled <br/ ><br>2. Volume of air exhaled <br/ ><br>3. Forced expiratory volume in one second(FEV1) <br/ ><br>4. Forced vital capacity (FVC) <br/ ><br>5. FEV1 divided by FVC (FEV1/FVC) <br/ ><br>6. PEF (Peak Expiratory Flow) <br/ ><br>7. FEF25-75% (Forced Expiratory Flow) <br/ ><br>8. FVC % Predicted <br/ ><br>9. FEV1 % Predicted <br/ ><br>10. FEV1 reversibility (ml) <br/ ><br>11. FEV1 reversibility % <br/ ><br>Timepoint: Same Day
Secondary Outcome Measures
NameTimeMethod
Turnaround time (TAT) will be calculated and compared for the following parameters for B.O.L.T. Spirometer with subsequent equivalent <br/ ><br>1. Device setup (installation) time <br/ ><br>2. Per-cycle loading and unloading time <br/ ><br>3. Overall time for the test <br/ ><br>Timepoint: same day
© Copyright 2025. All Rights Reserved by MedPath